Showing results (331-340 of 6,742) with videos related to
Sort By:
Pageof 675
European Journal of Neurology|December 17, 2021
Cognitive sequelae of long COVID may not be permanent: A prospective studyOscar H Del Brutto, Denisse A Rumbea, Bettsy Y Recalde, et al.European Journal of Neurology|December 22, 2021
Biallelic truncating variants in the muscular A-type lamin-interacting protein (MLIP) gene cause myopathy with hyperCKemiaLiat Salzer-Sheelo, Avi Fellner, Naama Orenstein, et al.European Journal of Neurology|November 8, 2021
Multimodal assessment of autonomic dysfunction in amyotrophic lateral sclerosisDavid Weise, Ina Menze, Moritz C F Metelmann, et al.European Journal of Neurology|November 8, 2021
Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trialPatrick Vermersch, Celia Oreja-Guevara, Aksel Siva, et al.European Journal of Neurology|December 4, 2021
Detecting myositis as a cause of unexplained dysphagia: Proposal for a diagnostic algorithmBendix Labeit, Thalia Grond, Achim G Beule, et al.European Journal of Neurology|August 3, 2019
Early changes in tests of peripheral nerve function during oxaliplatin treatment and their correlation with chemotherapy-induced polyneuropathy symptoms and signsT Krøigård, T K Svendsen, M Wirenfeldt, et al.European Journal of Neurology|August 14, 2019
Genotype-guided diagnostic reassessment after exome sequencing in neuromuscular disorders: experiences with a two-step approachM Krenn, M Tomschik, J Rath, et al.European Journal of Neurology|August 17, 2019
Preserved brain functional plasticity after upper limb task-oriented rehabilitation in progressive multiple sclerosisG Boffa, A Tacchino, E Sbragia, et al.European Journal of Neurology|September 28, 2022
Multiple sclerosis risk variants influence the peripheral B-cell compartment early in life in the general populationCasper L de Mol, Marvin M van Luijn, Karim L Kreft, et al.European Journal of Neurology|September 30, 2022
Clinical characteristics, treatments, outcome, and prognostic factors of severe autoimmune encephalitis in the intensive care unit: Standard treatment and the value of additional plasma cell-depleting escalation therapies for treatment-refractory patientsLisa Schwarz, Nilufar Akbari, Harald Prüss, et al.Pageof 675